SCHEMBL6489440

SCHEMBL6489440

OC(F)(Br)c1ccccc1F

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.42
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38
CCR6 P51684 1/20 0.38
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
PDK2 Q15119 3/20 0.35
PDK1 Q15118 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
ALDH1A1 P00352 2/20 0.35
ACHE P22303 1/20 0.35
SLC22A12 Q96S37 1/20 0.34
NFE2L2 Q16236 1/20 0.33
ESR2 Q92731 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777113 0.82 KCNN4 (0.44) KCNN4KCNE1KCNQ1CCR6CES2
SCHEMBL30757407 0.79 KCNN4 (0.41) KCNN4KCNE1KCNQ1CES2CES1
SCHEMBL1600455 0.79 KCNN4 (0.41) KCNN4KCNE1KCNQ1CES2CES1
SCHEMBL7206142 0.78 PDK1 (0.42) KCNN4KCNE1KCNQ1CCR6CES2
SCHEMBL5331319 0.78 KCNN4 (0.41) KCNN4KCNE1KCNQ1CCR6CES2
SCHEMBL24901411 0.78 MEN1 (0.46) KCNN4KCNE1KCNQ1PDK2PDK1
SCHEMBL2974843 0.77 KCNN4 (0.44) KCNN4KCNE1KCNQ1CES2CES1
SCHEMBL169053 0.76 SLC22A12 (0.46) KCNN4ALDH1A1ACHESLC22A12
SCHEMBL29466225 0.76 SLC22A12 (0.46) KCNN4ALDH1A1ACHESLC22A12
SCHEMBL10602905 0.76 KCNN4 (0.42) KCNN4KCNE1KCNQ1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256177-A1 Phenyl derivatives for the treatment of abnormal cell growth PFIZER INC 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256177-A1 Phenyl derivatives for the treatment of abnormal cell growth CCND3, CDC25C, CCNA1 KCNN4 3144/4885KCNE1 3618/4885KCNQ1 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.